HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acute and chronic effects of two different intravenous iloprost regimens in systemic sclerosis: a pragmatic non-randomized trial.

AbstractOBJECTIVES:
I.v. iloprost (ILO) may be used in the treatment of refractory RP and digital ulcers. We aim to evaluate the acute and chronic effects of two different ILO regimens by power Doppler US (PDUS) and nailfold videocapillaroscopy.
METHODS:
In this 3-month single-centre pragmatic non-randomized trial, 96 SSc patients were included and stratified according to ILO treatment as: no ILO (group A), ILO once monthly (group B) and ILO for five consecutive days (group C). Resistivity index (RI), finger pulp blood flow and periungual vascularization by PDUS, and sum of capillaries apex width in 1 mm by nailfold videocapillaroscopy were evaluated. Results were adjusted for the average outdoor temperature at the place of residence.
RESULTS:
An acute ILO effect was observed for only finger pulp blood flow in groups B and C (P < 0.001 and P < 0.005, respectively). An acute effect was observed for RI and periungual vascularization only in group B. A progressive increase was observed for other parameters without statistical difference. ILO effects were not observed any longer before the following infusion. Some parameters (finger pulp blood flow in group B and RI in group C) showed a statistically higher increase the lower the outdoor temperature was.
CONCLUSION:
ILO had an acute effect as assessed by PDUS, especially in group B. By contrast, an ILO chronic effect was not detectable before the following infusion in both treatment groups. More studies are needed to define how often ILO should be administered.
AuthorsTommaso Schioppo, Annalisa Orenti, Patrizia Boracchi, Orazio De Lucia, Antonella Murgo, Francesca Ingegnoli
JournalRheumatology (Oxford, England) (Rheumatology (Oxford)) Vol. 57 Issue 8 Pg. 1408-1416 (Aug 01 2018) ISSN: 1462-0332 [Electronic] England
PMID29733400 (Publication Type: Journal Article, Pragmatic Clinical Trial)
Chemical References
  • Vasodilator Agents
  • Iloprost
Topics
  • Administration, Intravenous
  • Adult
  • Aged
  • Aged, 80 and over
  • Dose-Response Relationship, Drug
  • Female
  • Fingers (blood supply)
  • Follow-Up Studies
  • Humans
  • Iloprost (administration & dosage)
  • Laser-Doppler Flowmetry
  • Male
  • Microscopic Angioscopy
  • Middle Aged
  • Regional Blood Flow (drug effects)
  • Retrospective Studies
  • Scleroderma, Systemic (diagnosis, drug therapy, physiopathology)
  • Time Factors
  • Treatment Outcome
  • Vasodilator Agents (administration & dosage)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: